Press Releases | Greenwich LifeSciences, Inc. (GLSI) | GP2

Apr 23, 2026 6:00am EDT

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026

Apr 22, 2026 5:00pm EDT

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

Apr 20, 2026 6:00am EDT

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026

Apr 14, 2026 6:00am EDT

Greenwich LifeSciences Provides Update on Financing Strategy

Apr 07, 2026 6:00am EDT

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential

Mar 19, 2026 6:00am EDT

Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01

Mar 18, 2026 6:00am EDT

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting

Mar 17, 2026 6:00am EDT

Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01

Mar 16, 2026 6:00am EDT

Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01

Mar 03, 2026 6:00am EST

Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01

1
2
3
4
5
6
7
8
9
10
…12
Next